Orgenesis Inc. Stock Based Compensation

Stock Based Compensation of ORGS for past 10 years: annual, quarterly and twelve month trailing (TTM) including Stock Based Compensation growth rates and interactive chart.


Highlights and Quick Summary

  • Stock Based Compensation for the quarter ending March 31, 2022 was $815 Thousand (a 44.5% increase compared to previous quarter)
  • Year-over-year quarterly Stock Based Compensation increased by 163.75%
  • Annual Stock Based Compensation for 2021 was $1.75 Million (a -91.23% decrease from previous year)
  • Annual Stock Based Compensation for 2020 was $19.9 Million (a 249.16% increase from previous year)
  • Annual Stock Based Compensation for 2019 was $5.7 Million (a 11.77% increase from previous year)
  • Twelve month Stock Based Compensation ending March 31, 2022 was $1.98 Million (a 13.52% increase compared to previous quarter)
  • Twelve month trailing Stock Based Compensation decreased by -2.8% year-over-year
Trailing Stock Based Compensation for the last four month:
31 Mar '22 31 Dec '21 30 Sep '21 30 Jun '21
$1.98 Million $1.75 Million $1.76 Million $2.04 Million
Visit stockrow.com/ORGS for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Stock Based Compensation of Orgenesis Inc.

Most recent Stock Based Compensationof ORGS including historical data for past 10 years.

Interactive Chart of Stock Based Compensation of Orgenesis Inc.

Orgenesis Inc. Stock Based Compensation for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 $0.82
2021 $0.56 $0.29 $0.31 $0.58 $1.75
2020 $0.58 $0.57 $17.88 $0.87 $19.9
2019 $0.63 $0.46 $0.89 $3.71 $5.7
2018 $1.38 $1.89 $0.78 $1.04 $5.1
2017 $0.11 $2.03 $0.68 $3.36
2016 $0.43 $1.66 $2.87
2015 $0.8
2014 $2.49
2013 $3.12

Business Profile of Orgenesis Inc.

Sector: Healthcare
Industry: Biotechnology